Kevin C De Braganca

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Adam David Cohen, Samir Parekh, Bianca D Santomasso, Jaime Gállego Pérez-Larraya, Niels W C J van de Donk, Bertrand Arnulf, Maria-Victoria Mateos-Manteca, Nikoletta Lendvai, Carolyn C Jackson, Kevin C De Braganca, Jordan M Schecter, Loreta Marquez, Erin Lee, Ingrid Cornax, Enrique Zudaire, Claire Li, Yunsi Olyslager, Deepu Madduri, Helen Varsos, Lida Pacaud, Muhammad Akram, Dong Geng, Andrzej J Jakubowiak, Hermann Einsele, Sundar Jagannath
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood cancer journal 12 (2) (2022)
Adam David Cohen, Maria-Victoria Mateos-Manteca, Yael C Cohen, Paula Rodriguez Otero, Juan José Lahuerta, Niels W C J van de Donk, Thomas G Martin, Attaya Suvannasankha, Kevin C De Braganca, Christina Corsale, Jordan M Schecter, Helen Varsos, William Deraedt, Liwei Wang, Martin Vogel, Tito Roccia, Xiaoying Xu, Pankaj Mistry, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Jesús San F Miguel
Efficacy and safety of cilta-cel in patients with progressive MM after exposure to other BCMA-targeting agents. Blood (2022)

Kevin C De Braganca.css-eqlu8i{font-size:small;padding-left:4px;}